文献速递肾移植肾小球疾病

供者APOL1高危基因型与移植肾新发塌陷性肾小球病风险及预后不良相关

Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
PubMed 文献 · Kidney Int · 2018-10-02

该研究纳入38例肾移植术后新发塌陷性局灶节段性肾小球硬化(cFSGS)患者,分析其临床病理特征与供者APOL1风险基因型。结果显示61%合并急性排斥、47%供肾来自非裔美国人供者(其中53%携带APOL1高危基因型),63%发生移植肾失功;供者APOL1高危基因型可独立预测不良结局。

要点

  • 移植后新发cFSGS预后差,63%患者平均18个月发生移植肾失功
  • 供者APOL1高危基因型与cFSGS发生率升高及移植物生存不良独立相关
  • 非裔供者、急性排斥、病毒感染和急性血管闭塞可能是易感因素

核心结论

  • 移植后新发cFSGS蛋白尿程度不一、预后差,供者APOL1高危基因型与更高发病率和更差移植物生存相关。

研究设计与样本

  • 回顾性分析38例肾移植术后新发cFSGS患者的临床病理特征及供者APOL1风险基因型;受者34%为女性、26%为非裔美国人。

主要发现

  • 61%合并急性排斥,47%供肾来自非裔美国人供者且其中53%携带APOL1高危基因型,均显著高于本中心总体移植人群的35%和16%。
  • 患者中位血肌酐5.4 mg/dl、尿蛋白/肌酐3.5 g/g,18%有肾病综合征,63%在指数活检后平均18个月发生移植肾失功。
  • 单因素分析中供者APOL1高危基因型、移植后时间、肾病综合征和慢性组织学改变与较差移植物生存相关,急性血管闭塞与较好移植物生存相关;供者APOL1高危基因型独立预测不良结局。
  • 与自体肾cFSGS相比,移植后cFSGS急性血管闭塞更多而蛋白尿较少。

临床怎么用

  • 移植后新发cFSGS应评估供者APOL1高危基因型以进行风险分层,并警惕急性排斥、病毒感染及急性血管闭塞等潜在诱因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Collapsing focal segmental glomerulosclerosis (cFSGS) in the native kidney is associated with heavy proteinuria and accelerated renal failure. However, cFSGS in the renal allograft is less well characterized. Here we report clinico-pathologic features and APOL1 donor risk genotypes in 38 patients with de novo post-kidney transplant cFSGS. Recipients were 34% female and 26% African American. Concurrent viral infections and acute vaso-occlusion (including thrombotic microangiopathy, cortical necrosis, atheroembolization, and cardiac arrest with contralateral graft thrombosis) were present in 13% and 29% of recipients, respectively. Notably, 61% of patients had concurrent acute rejection and 47% received grafts from African American donors, of which 53% carried APOL1 high-risk genotypes. These frequencies of acute rejection and grafts from African American donors were significantly higher than in our general transplant population (35% and 16%, respectively). Patients had a median serum creatinine of 5.4 mg/dl, urine protein/creatinine 3.5 g/g, and 18% had nephrotic syndrome. Graft failure occurred in 63% of patients at an average of eighteen months post-index biopsy. By univariate analysis, donor APOL1 high-risk genotypes, post-transplant time, nephrotic syndrome, and chronic histologic changes were associated with inferior graft survival while acute vaso-occlusion was associated with superior graft survival. Donor APOL1 high-risk genotypes independently predicted poor outcome. Compared to native kidney cFSGS, post-transplant cFSGS had more acute vaso-occlusion but less proteinuria. Thus, de novo cFSGS is associated with variable proteinuria and poor prognosis with potential predisposing factors of African American donor, acute rejection, viral infection and acute vaso-occlusion. Additionally, donor APOL1 high-risk genotypes are associated with higher incidence and worse graft survival.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Santoriello D, Husain SA, De Serres SA, et al. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts. Kidney Int. 2018. PMID: 30287079. doi:10.1016/j.kint.2018.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。